ABOUT THE IBEX SECOND READ™ APPLICATION
The first-ever AI-based cancer diagnosis solution in a pathology lab, the CE-Marked Ibex Second Read™ application has already demonstrated success in identifying missed prostate cancer cases. The Second Read™ application analyses biopsies using AI-based algorithms, searching for cancerous tissue and various other anomalies.
This is performed with no impact on the pathologist’s workflow. Once the pathologist diagnoses a case, the application compares its findings with the pathologists and alerts in case of high probability discrepancies between the two.